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Abstract
 
Monocytes can develop into dendritic cells (DCs) that migrate to lymph nodes (LNs) and
present antigens to T cells. However, we find that this differentiation is blocked when mono-
cytes accumulate subcutaneously in response to bacteria or lipopolysaccharide (LPS). The inhibition
of DC differentiation is mediated by the bacteria and in conjunction with inflammatory cells
recruited at the site of injection. Inhibition of migratory DC development was reversed in
Toll-like receptor (TLR)4-mutated mice when LPS, but not whole bacteria, was injected,
suggesting that TLR4 is one but not the only mediator of the inhibition. The block imposed
by bacteria was partly relieved by the absence of interleukin (IL)-12 p40, but not by individual
absence of several cytokines involved in DC differentiation or in inflammation, i.e., IL-6, IL-10,
IL-12 p35, and interferon 
 
 
 
. Consistent with the inability of monocytes to yield migrating
DCs, and the finding that other DCs had limited access to particulate or bacterial antigens,
these antigens were weakly presented to T cells in the draining LN. These results illustrate that
bacteria-associated signals can have a negative regulatory role on adaptive immunity and that
local innate responses for containment of infectious bacteria can at least initially supersede
development of adaptive responses.
Key words:
 
Salmonella typhimurium
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Introduction
 
DCs are professional APCs that are located in lymphoid
and nonlymphoid tissues where they perform a sentinel
function for incoming pathogens (1, 2). Although a steady-
state migration of DCs to secondary lymphoid organs occurs,
systemic injection of LPS or inflammatory cytokines has
been shown to enhance the mobilization of tissue resident
DCs from the periphery to secondary lymphoid organs (3,
4). Migrating DCs can also originate primarily from blood
monocytes (5, 6). An estimated 25% of the circulating inflam-
matory monocytes will differentiate into migrating DCs,
whereas the others will give rise to resident macrophages
(5, 7). What drives the differentiation from monocytes into
DCs or macrophages in vivo is still unknown, but it has
been shown that cytokines or environmental factors can
play a role in skewing either pathway of differentiation in
vitro (8–15). It is conceivable that the differentiation of
monocytes into DCs or macrophages in body tissues is
shaped by the local environment present during their transit
and that there can be situations that favor the development
of one or the other cell type. As DCs have been shown to
be required for cytotoxic T cell responses to intracellular
bacteria (16) and priming of T cells takes place in the draining
LN (DLN; 17), the capacity to generate migrating DCs after
infection could be crucial to induce adaptive immunity
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against the invading microbes. Thus, we have analyzed all
the steps during the induction of an immune response to
 
Salmonella typhimurium
 
 injected subcutaneously from DC
differentiation and migration, to the activation of antigen-
specific T lymphocytes.
We show that intradermal (i.d.) injection of dead or
alive 
 
S. typhimurium
 
, or simply LPS, induces a potent local
innate inflammatory response that blocks monocyte-
derived DC differentiation and migration to the DLN to
present antigen to T cells. This is in agreement with our
previous results showing that subcutaneous injection of 
 
S.
typhimurium
 
, recombinant for the melanoma antigen ty-
rosinase-related protein 2, does not protect from lethal chal-
lenge with B16 melanoma, whereas DCs loaded in vitro
with the same bacteria can potently limit tumor growth
(18). Although numerous studies show that inflammatory
mediators can promote adaptive immune responses by
promoting maturation of DCs, we show here that the re-
sult can be dramatically different when the precursors of
the antigen-presenting DCs, in this case monocytes, en-
counter the inflammatory/pathogenic signal before com-
mitting to the DC pathway of differentiation in vivo. Our
results reveal a capacity of the innate inflammatory reac-
tion to inhibit adaptive immune responses to particulate
antigens.
 
Materials and Methods
 
Cells and Reagents.
 
Conditioning medium for DCs was
IMDM (Sigma-Aldrich) containing 10% heat-inactivated fetal
bovine serum (Life Technologies), 100 IU/ml penicillin, 100 
 
 
 
g/
ml streptomycin, 2 mM 
 
l
 
-glutamine (all from Sigma-Aldrich),
and 50 
 
 
 
M 2-mercaptoethanol, supplemented with 30% superna-
tant from GM-CSF–producing NIH/3T3 cells.
Inflammatory monocytes were collected from the peritoneal
cavity of mice injected i.p. with 1 ml of a PBS solution contain-
ing 4% thioglycollate medium (Sigma-Aldrich) and then 18 h
later with 0.5 ml FITC-conjugated 1-
 
 
 
m latex particles (0.02%
wt/vol). Mice were killed 4 h later for peritoneal lavage. In some
experiments this cell preparation was subjected to cell sorting,
wherein latex
 
  
 
cells (all F4/80 low) were gated and purified.
These cells were then cultured in vitro in DC conditioning me-
dium in the presence or absence of bacteria and in the presence or
absence of the latex
 
  
 
fraction (
 
 
 
80% neutrophils) from the same
sort of peritoneal cells.
 
Mice.
 
5–6-wk-old female C57/BL6J (Ly5.2), C57/BL6J
(Ly5.1), C3H/HeJ, C3H/HeN, or BALB/c mice were pur-
chased from Charles River Laboratories. DO11.10 OVA-TCR
transgenic T cells were provided by D. Lo (Scripps Research
Institute, La Jolla, CA). IFN-
 
  
 
(BALB/c-Ifg[tm1 129]), IL-12p35
(C.129S1(B6)-Il12atm1Jm), and IL-12p40 (C.129S1-Il12btm1Jm)
KO mice on a BALB/c background were purchased from The
Jackson Laboratory. p35/IFN-
 
  
 
double KO was obtained by in-
terbreeding mice selected for carrying the double mutation from
the F2 generation. BALB/c IL6 KO mice were provided by P.
Sacerdote (University of Milan, Milan, Italy). MyD88-deficient
mice were on a C57BL/6 background and were continuously
fed antibiotics. The antibiotics had no effect on the migration
of monocyte-derived DCs as assessed in control mice also fed
antibiotics.
 
Antibodies, Cell Surface Phenotype, and Assessment of Cell
Death.
 
The following monoclonal antibodies were purchased
from BD Biosciences: CD4 (L3T4), CD8a (Ly2), I/A-b, I/A-d,
CD11b (Mac-1), CD11c (N418), CD45R (B220), Gr1 (Ly-6G),
and CD45.2 (104). An IgG with specificity to neutralize mIL-10
was purchased from R&D Systems. F4/80 was purified from su-
pernatant of the relevant hybridoma (HB198).
Staining was performed with 50 
 
 
 
g/ml propidium iodide to
evaluate dead cells and flow cytometry analysis was performed
with a FACScan™ (CELLQuest™ software; Becton Dickinson).
 
Bacterial Strains and Preparation for Injections. S.  typhimurium
 
SL7207 (
 
S. typhimurium
 
 233765 derivative hisG46, DEL407
[aroA::Tn10{Tc-s}]) was provided by B.A.D. Stocker (Stanford
University School of Medicine, Stanford, CA). Two recombinant
strains of SL7207 were generated expressing either the gene cod-
ing for GST-OVA fusion (SL7207-OVA), or with the GST alone
(SL7207 pGEX; reference 18). 10
 
7 
 
CFUs of SL7207-OVA ex-
press nearly 1 
 
 
 
g protein. 
 
Bacillus subtilis
 
 was provided by A. Ga-
lizzi (University of Pavia, Pavia, Italy). Single colonies were
grown overnight at 37
 
 
 
C in lurian broth (LB; Difco) and restarted
the next day at 1:10 of the original volume up to the following:
for Salmonella an 0D
 
600 
 
  
 
0.35, which corresponds to 7 
 
  
 
10
 
8
 
CFU/ml and for 
 
B. subtilis
 
 to an 0D
 
600 
 
  
 
1.0, which corresponds
to 2 
 
  
 
10
 
8 
 
CFU/ml.
 
Leishmania mexicana
 
 (strain MNYC/BZ/62/M379) promasti-
gotes, recently isolated from mice, were grown to stationary
phase in culture. Parasites were washed thoroughly with PBS and
injected at 3 
 
  
 
10
 
6 
 
parasites per site of injection.
 
Mice Treatments, Skin Inflammation Induction, and Latex Migra-
tion.
 
Mice were anesthetized i.p. with Avertin 2.5% and shaved
in four sites of the dorsal skin, which were drained either by the
inguinal or brachial LNs. 10
 
7
 
, 5 
 
  
 
10
 
4
 
, or 10
 
2 
 
CFUs of bacteria
were diluted to a final volume of 10 
 
 
 
l PBS and injected i.d. us-
ing a Hamilton syringe (Fisher Scientific). 10
 
7 
 
FITC-conjugated
latex particles of 1 
 
 
 
m in diameter (Polysciences) were injected as
tracers in the presence or absence of bacteria. Migration of I-A
 
b
 
 
 
or CD11c
 
  
 
cells carrying latex to DLNs was assessed 1, 2, or 3 d
after treatment. At indicated times, mice were killed and DLNs
were collected, teased, and cells were released by treatment with
0.25% collagenase at 37
 
 
 
C for 25 min (Collagenase D; Roche).
Cells were stained for I-A
 
b 
 
or CD11c expression. For quantifica-
tion, the entire population of DLN cells was acquired by cytoflu-
orometry and absolute numbers of CD11c
 
  
 
or I-Ab
 
  
 
cells carry-
ing latex beads were determined per LN. The region of the skin
corresponding to the site of injection, as identified by faint visual
appearance of green latex beads, was separated and cells were re-
leased after collagenase treatment and stained for FACS
 
® 
 
analysis
as described above.
 
Adoptive Transfer of Peritoneal Inflammatory Monocytes or of
Cells from Infected Skins.
 
Latex
 
  
 
inflammatory monocytes from
C57BL/6 Ly5.2 mice were collected from peritoneal lavage as
described above. 1–1.25 
 
  
 
10
 
6 
 
cells were injected i.d. in C57BL/6J
Ly5.1 mice in the presence or absence of 10
 
7 
 
CFUs of SL7207.
3 d later, mice were killed, DLNs were collected, and CD45.2
 
 
 
/
latex
 
  
 
cells were released and analyzed by FACS
 
® 
 
analysis.
For adoptive transfer of cells from infected skins, mice were
injected i.d. with 10
 
7 
 
CFUs of SL7207. 2 d later, cells were col-
lected and remaining extracellular bacteria were killed by incu-
bation with 100 U/ml streptomycin, 10 
 
 
 
g/ml tetracycline, and
50 
 
 
 
g/ml gentamicin for 2 h at 37
 
 
 
C. 10
 
6 
 
cells were injected i.d.
in C57BL/6J Ly5.1 mice. 3 d later, mice were killed, DLNs
were collected, and CD45.2
 
 
 
/latex
 
  
 
cells were analyzed as de-
scribed above.T
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Topical Application of Soluble FITC (FITC Paint).
 
FITC
(Sigma-Aldrich) was dissolved in acetone/dibutylphthalate at a
concentration of 8 mg/ml and 25 
 
 
 
l were applied to each region
of the shaved dorsal skin corresponding to the areas of bacterial
injection as previously described (5).
 
Covalent Coupling of Latex Particles with OVA and Immunization
Protocol.
 
1 
 
 
 
m carboxylated FITC-labeled latex beads were pur-
chased from Polyscience. Covalent coupling with OVA was per-
formed according to the manufacturer’s instructions (Poly-
science), except for 50 mM 2-(
 
N
 
-Morpholino)-ethanesulfonic
acid, pH 6.5, which was used as coupling buffer. Spectrophoto-
metric evaluation of sample showed that 10
 
7 
 
microspheres were
coated with 0.25 
 
 
 
g OVA. Mice were immunized with 10
 
7 
 
mi-
crospheres or with an equivalent amount of soluble OVA (0.25
 
 
 
g) in the presence or absence of increasing concentrations of
bacteria (10
 
2
 
–10
 
7
 
). Four 10-
 
 
 
l injections were performed in the
dorsal skin of mice.
 
TCR Transgenic T Cells Adoptive Transfer.
 
DO11.10 TCR-
OVA T cells, specific for the OVA
 
327–339 
 
peptide in association
with I-A
 
d
 
, were collected from spleen, brachial, and inguinal LNs.
CD4
 
  
 
T cells were purified by positive selection using 
 
 
 
-CD4
(L3T4) magnetic microbeads (Mini-MACS; Miltenyi Biotec) and
cells were labeled with 5 
 
 
 
M carboxyl-fluorescein-succinimidyl
ester (CFSE) for 15 min at 37
 
 
 
C (Molecular Probes).
BALB/c recipient mice were injected i.v. with 3 
 
  
 
10
 
6
 
DO11.10 CFSE-labeled T cells and then immunized with four
different treatments. We injected 0.25 
 
 
 
g soluble or latex-bound
OVA with increasing concentrations of bacteria (10
 
2
 
–10
 
7 
 
CFUs).
Alternatively, mice were injected either with 3 
 
  
 
10
 
5 
 
BALB/c
BM DCs loaded in vitro with 50 
 
 
 
g soluble OVA in the presence
or absence of 10
 
7 
 
CFUs of bacteria, or with 10
 
2
 
, 5 
 
  
 
10
 
4
 
, or 10
 
7
 
CFUs of SLpOVA or SLpGEX (as a control). Mice injected with
10 
 
 
 
l of either 0.25 
 
 
 
g OVA, CFA, or 0.25 
 
 
 
g OVA emulsified
in CFA were always included in each experiment as a control. 3 d
later, DLNs were collected and DO11.10 T cell proliferation was
assessed as reduction in CFSE labeling.
 
Intracellular Survival of Bacteria.
 
4 
 
  
 
10
 
6 
 
cells from spleen and
DLNs of injected mice were lysed with 0.5% sodium deoxycholate.
CFUs were counted after serial dilution of cellular lysates on LB
agar to quantify the number of migrated live intracellular bacteria.
 
Online Supplemental Material.
 
CD14
 
 
 
 cells were positively se-
lected from buffy coats using magnetic column separation (Mil-
tenyi Biotech). Cells were cultured for 7 d at a concentration of
10
 
6
 
/ml in RPMI (Cambrex) supplemented with 10% FBS
(GIBCO BRL), 2 mM 
 
l
 
-glutamine (Euroclone), 50 ng/ml
rhGM-CSF, 20 ng/ml rhIL4 (PeproTech), and 100 mg/ml gen-
tamicin (Roche). At days 2, 4, and 6, to generate “inflammatory
monocytes,” cells were preactivated with 20 ng/ml rhTNF
 
 
(Sigma-Aldrich) 4 h before bacterial encounter. SL7207 was then
added at an MOI of 20:1 for 1 h in the absence of antibiotics. After
incubation with bacteria, the medium was changed and antibiotics
were added again. At d 7, cells were collected and analyzed by flow
cytometry with the indicated antibodies. Fig. S1 is available at
http://www.jem.org/cgi/content/full/jem.20030335/DC1.
Results
Gram-negative Bacteria Block DC Migration to the DLN.
To evaluate the ability of DCs to take up, migrate, and
transport skin-injected bacteria to DLNs, we used a meta-
bolically defective strain of S. typhimurium (aroA strain
SL7207) expressing the green fluorescent protein (GFP).
We performed i.d. injections in the dorsal skin of C57BL/6
mice using different concentrations of bacteria ranging
from 102 to 107 CFUs. 1, 2, or 3 d later we collected the
draining brachial and inguinal LNs and analyzed the total
cellular content for GFP  cells. To our surprise, we could
not detect any GFP  cells present in the DLNs (unpub-
lished data ). As this was possibly due to the capacity of
DCs to efficiently kill salmonella and metabolize the GFP,
we coinjected the bacteria with a nondegradable fluores-
cent tracer (FITC latex beads) to follow DC migration, us-
ing a previously described method (5). In Fig. 1 A (left),
the total DLN cellular content of I-Ab /bead  cells, which
Figure 1. Bacteria block latex /I-Ab  cells migration from the injection
site. (A) Bacteria induce a complete and immediate block of latex  DC
migration. 107 fluorescent latex microspheres/site were injected i.d. in
mice in four different sites in the presence or absence of 107 CFUs of
Salmonella. Mice were killed at days 1, 2, and 3 after treatment and the
total number of I-Ab  cells carrying FITC  latex particles per DLN was
assessed after acquisition of the whole sample. Log fluorescence of latex
microspheres is indicated on the x axis where at least two alignments of
latex are clearly detectable, indicating cells containing one and two particles,
respectively. Log fluorescence of I-Ab  is indicated on the y axis. These
data are representative of several experiments, each performed in triplicate.
(B) The block of DC migration is dependent on bacteria concentration.
Again the total cellular content of the DLN for each condition was
acquired and the efficiency of total latex  cell migration 3 d after treatment
as compared with that in control mice (100%) is reported.T
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paralleled the migration of CD11c /bead  cells (unpub-
lished data), is shown. Cells carrying one, two, or more
beads could be easily observed (especially on or after the
second day) in the absence of bacteria. By contrast, coin-
jection of bacteria (107 CFUs) with 107 FITC latex com-
pletely blocked migration of I-Ab /bead  cells from the in-
fected site to the DLN at days 1, 2, or 3 after injection (Fig.
1 A, right). The block of bead  cell migration was depen-
dent on the dose of bacteria injected, being maximal at 107
CFUs (Fig. 1 B), but substantial inhibition was observed at
much lower doses (65% inhibition using 5   104 CFUs).
We also tested the capacity of Escherichia coli (DH5 ) to
block the migration of bead  DCs and we observed similar
results (unpublished data). Therefore, Gram-negative bac-
teria inhibit the migration of bead-bearing DCs from pe-
ripheral tissues to DLNs in a dose-dependent manner.
Inhibition of Latex-bearing DC Mobilization Is Due to Local
Factors. Next, we investigated whether bacteria were in-
ducing a systemic or a local block of latex-bearing DC mi-
gration. 107 FITC latex beads were injected i.d. either
alone, as a positive control, or together with bacteria (107
CFUs) as a negative control, or contralaterally from bacte-
rial injection to assess whether bacteria were controlling
DC migration from a distant site. Injection of bacteria con-
tralaterally from FITC latex beads did not affect DC migra-
tion, whereas coinjection of latex plus bacteria resulted
again in block of DC migration (unpublished data). There-
fore, local but not distal factors released by bacteria or by
neighboring tissue cells mediate the block of DC migra-
tion. Similarly, also Gram-positive bacteria, such as Bacillus
subtilis (107 CFUs), or parasites, such as L. mexicana (3  
106 stationary phase promastigotes), impaired DC migra-
tion, although the block was not as complete as with
Gram-negative bacteria (Fig. 2 A).
Inactivated Bacteria or Simply LPS Are Sufficient to Inhibit
DC Migration. It has been shown that Schistosoma mansoni
can release soluble lipophilic factors able to block Langer-
hans cells (LCs) migration induced by TNF-  via binding
to the adenylate cyclase-coupled PGD2 receptor (19). Simi-
larly, live bacteria could release metabolites or factors in
situ which could interfere with DC function and migra-
tion. Thus, we analyzed whether inactivated bacteria could
still influence DC mobilization. S. typhimurium was inacti-
vated as described in Materials and Methods. In all cases, a
block in DC migration, similar to that induced by live bac-
teria, was observed (Fig. 2 B). Finally, we asked if a com-
ponent of Gram-negative bacteria cell wall, such as LPS,
was also able to affect DC migration. As shown in Fig. 2 C,
increasing the concentration of i.d. injected LPS ( 1  g)
inhibited DC migration. Thus, neither viable nor intact
Gram-negative bacteria are required to block DC mobili-
zation, excluding the possibility that abrogation of DC mi-
gration is due to metabolic factors released by the microor-
ganisms. Moreover, the fact that LPS was able to reduce
DC migration favors the possibility that engagement of
Toll-like receptor (TLR)4 regulates DC differentiation
and/or migration.
Figure 2. Inhibition of DC mobilization can be induced also by Gram-
positive bacteria, parasites, inactivated bacteria, and bacterial LPS. (A) Not
only Gram-negative, but also Gram-positive bacteria like Bacillus subtilis
(BS) or parasites like L. mexicana are able to reduce latex  cell migration.
Efficiency of latex  cell migration as compared with migration of latex 
cells in control mice (100%) 3 d after injection, is reported. (B) Viability
of bacteria is not necessary to impede DC migration. Bacteria were killed
in different ways to ensure that the method of inactivation was not affecting
latex  cell migration. (C) LPS from E. coli blocks latex  cell migration to
DLNs at concentrations  1  g.
Figure 3. Bacteria do not substantially affect LCs migratory properties.
(A) LCs are able to migrate to DLNs even in the presence of subcutane-
ously injected bacteria. LCs residing in the epidermis were sensitized with
soluble FITC directly painted on the skin of shaved mice. Cytofluorometry
analysis of CD11c  FITC  cells migrated from skins of mice injected in
the same site (FITC paint   BT), contralaterally (FITC PAINT   BT
contralaterally), or noninjected (FITC paint only) with bacteria is reported.
All these data are representative of two or more experiments each per-
formed in triplicate.T
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Block of DC Migration Affects Only DCs in the Site of Injec-
tion. If the inflammatory response generated in the im-
mediate vicinity of the injection physically impeded DC
mobilization, we would expect that DC migration from
proximal regions, which are not directly localized within the
inflammatory response, to be unaffected by the presence of
bacteria. Thus, we investigated, by means of epicutaneous
application of contact sensitizers, the capacity of epidermal
LCs overlying the site of injection to migrate to DLNs in
the presence or absence of bacteria injected i.d. Using the
contact sensitizer FITC, we painted the skin of mice that
received bacteria intracutanously and followed FITC  LCs
migration to the draining node. As shown in Fig. 3, FITC 
CD11c  DC migration to DLNs was not affected by the
presence of bacteria. Rather, a slight increase of FITC 
cells was observed, confirming that the effect is confined
strictly to the site injection and inflammatory focus, and/or
is restricted in its effect to certain DCs or DC precursors,
such as the monocyte-derived cells that most efficiently ac-
quire phagocytic particulates in the dermis (5).
Absence of DC Migration Correlates with Defect in Immune
Response. As already described, FITC microspheres as a
particulate antigen are unable to gain access to the DLNs in
the absence of cellular transport (5). Thus, we can assume
that the majority of the beads recovered from the DLNs are
actively transported by phagocytes migrating from the pe-
riphery. As injection of increasing concentrations of bacte-
ria progressively blocks DC migration from peripheral
tissues, we would expect to gradually dampen T cell
proliferation to a model antigen covalently coupled to latex
beads when coinjecting the beads with progressively higher
doses of bacteria. Thus, latex beads were coupled with the
model antigen OVA and OVA-specific transgenic T cells
(from DO11.10 mice) were used to follow T cell expan-
sion in vivo according to the protocol established by Kear-
ney et al. (20). The population of transferred T cells was
tracked by flow cytometry as CD4  CFSE  cells, and cell
division was evaluated as subsequent reduction in the asso-
ciated CFSE fluorescence. As shown in Fig. 4 A, prolifera-
tion of OVA-specific T cells to latex OVA is inhibited in a
dose-dependent manner by bacteria. Keeping constant the
number of OVA latex beads, the number of T cell divisions
is progressively reduced to no detectable divisions at 107
bacteria. T cell proliferation induced by soluble OVA that
could escape the inflammatory region and be taken up by
APCs distally was not affected by increasing concentrations
of bacteria (Fig. 4 B). We then injected S. typhimurium ex-
pressing the GST-OVA fusion protein (SL-pOVA), or the
same strain expressing only the GST (SL-pGEX), as a con-
trol. As shown in Fig. 4 C, only at a very high concentra-
tion (107 CFUs) of SL-pOVA could some response be de-
tected, which was much lower than that induced by latex
OVA even though the amount of OVA delivered by the
bacteria was four times higher than that released by the
beads (refer to Materials and Methods). This correlated
with the recovery of very few bacterial colonies in DLNs,
probably due to free bacteria escaping from the inflamma-
tory site (Fig. 4 D). These results were not due to a gener-
alized and direct inhibitory effect of the bacteria on DC
migration because when OVA-loaded, bone marrow–
derived DCs were coincubated with bacteria (107 CFUs) in
vitro, and then extensively washed before injection in vivo,
a good T cell proliferative response was detected (Fig. 4 E).
Altogether, these experiments indicate that not only is pre-
sentation of a model antigen coupled to latex impaired, but
also the same antigen expressed within bacteria is not pre-
Figure 4. Bacteria block T cell proliferation after administration of
particulate or “bacterial,” but not soluble, antigens. (A) A dose-dependent
inhibition of T cell proliferation to particulate antigen is observed in the
presence of bacteria. BALB/c recipient mice were transferred with
CFSE-labeled DO11.10 CD4  T cells. 107 carboxylated microspheres
covalently coupled with 0.25  g OVA protein were injected i.d. together
with increasing concentrations of bacteria (range: 102–107 CFUs). Dot
plots of CD4  CFSE  T cells collected from DLNs 3 d after subcutaneous
injections are reported. (B) 0.25  g soluble OVA reaches the DLNs in
the absence of cellular transport and is presented by resident APCs to activate
T cells also when coinjected with increasing concentrations of bacteria.
(C) “Bacterial” recombinant OVA induces the proliferation of DO11.10
T cells only after injection of high amounts (107 CFUs) of bacteria. Lower
doses of bacteria or control nonrecombinant BTpGEX (first panel) did
not induce DO11.10 T cell proliferation. (D) Only after injection of 107
CFUs of bacteria could some CFUs be recovered in DLNs, but not in the
spleen. Bacterial escape from the site of injection was evaluated by collecting
cells from spleen and DLNs of treated mice and by plating cellular lysates
on LB agar. (E) DCs loaded with soluble OVA induce good T cell pro-
liferative responses when either injected alone or after washing out co-
incubated bacteria. BSA-loaded BM DCs were used as a negative control
in these experiments.T
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sented due to failure of the antigen to reach the DLN
within DCs and thereby promote T cell proliferation.
DCs Are Not Trapped at the Site of Bacterial Injection. A
common feature that accompanied the defect in DC mi-
gration was the formation of a strong inflammatory reac-
tion at the site of bacterial injection. We pursued three hy-
potheses for the block of DC migration: (a) the possibility
that the massive presence of Salmonella might be toxic and
induce the death of latex  cells; (b) that latex  DCs might
be trapped in the inflammatory area; and (c) alternatively,
as latex  DCs migrating to DLNs from the skin derive pri-
marily from monocytes during their transit into the tissue
(5), it seemed possible that the presence of bacteria at the
site of injection inhibits DC differentiation from mono-
cytes, thereby blocking their migration into DLNs. Thus,
we addressed each one of these possibilities. At days 1, 2, or
3, the tissue corresponding to the injection site was ana-
lyzed either by cytofluorometry or by immunohistochem-
Figure 5. Inflamed skin cells are not undergoing massive cell death and LN latex  cells derived from peritoneal monocytes display features of mature
DCs. (A) Only 10% of latex  cells from the inflamed skin cell suspension are also propidium iodide  (dead). Two-color FACS® analysis of FITC latex 
cells and propidium iodide was performed on cells collected from injected site 36 h after injection of 107 bacterial CFUs. (B) Peritoneal monocytes
loaded with FITC  latex beads display features of mature DCs when they reach the DLN. Isolated peritoneal monocytes express intermediate levels of
Gr1, are negative for CD11c, B7.2, and CD40, and are all positive for FITC latex beads (top). LN latex  monocyte-derived DCs down-regulate the
expression of Gr1 and up-regulate the expression of CD11c, MHC II, B7.2, and CD40. Open histogram profiles show phenotype of gated CD11c  cells
and filled profiles show gated CD11c  cells. (C) Frozen sections of LNs examined 3 d after adoptive transfer were stained with B220 or DEC-205,
detected with Cy3-conjugated secondary mAb (red). Latex-bearing cells are visualized by green fluorescence.
Figure 6. Bacteria impede DC
differentiation from monocytes.
(A) Latex  cells from peritoneal
lavage displayed typical features
of inflammatory monocytes: inter-
mediate levels of Ly6-c and I-Ab,
no CD11c, no B7.2, and low
CD40. Peritoneal monocytes
differentiated in DCs after 2 d of
culture in GM-CSF–containing
medium. By contrast cells ob-
tained at day 2 from the site of
bacteria/latex injection in skin
did not show signs of DC devel-
opment after recovery from the
skin, and they retained a “mono-
cyte” phenotype also after 2 or
4 d of culture in GM-CSF–
containing medium. (B) Bacteria
impede the migration of coin-
jected latex-bearing inflammatory
monocytes. Latex   monocytes
were collected from peritoneal
lavage of mice treated with
thioglycollate for 18 h and with
FITC latex solution for an addi-
tional 4 h. Inflammatory mono-
cytes were injected i.d. in the
presence or absence of bacteria.
DLNs were analyzed 3 d after
injection for the presence of
latex   cells. (C) Inflammatory
monocytes but not inflammatory
cells from bacteria-injected skins
are able to produce migrating
monocyte-derived DCs. CD45.2 
peritoneal inflammatory monocytes (left) or 2 d–infected skin cells (right) were cultured for 2 h in medium containing antibiotics to kill extracellular
bacteria, washed, and injected i.d. in Ly5.1 mice in the absence of bacteria. LN Ly5.2-latex  migrated cells are shown 3 d after injection. These results
are representative of three independent experiments.T
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istry for the expression of the following markers: Gr-1,
CD11c, CD11b, F4/80, B220, I-Ab, CD4, and CD8. The
cell suspension was also stained for propidium iodide to
evaluate the amount of cell death. It is unlikely that apop-
tosis or necrosis accounts for diminished DC migration be-
cause a maximum of 10% latex  cells were also positive for
propidium iodide (Fig. 5 A). Only a few macrophages (F4/
80hi cells) were found the first day but their number was in-
creased at later time points, whereas very few CD11c 
were found at any time points. Thus, we conclude that
latex  cells were confined to the infection site. This con-
clusion was supported by quantitation of the units of fluo-
rescence recovered after acetone extraction of the tissue at
the site of microsphere injection. We found that 100% of
initial injected fluorescence was recovered 3 d after coin-
jection of latex and bacteria (unpublished data), whereas
 25% of the fluorescence units leave the injection site
within migratory cells in the absence of bacteria (5). The
immunohistochemistry of the Salmonella-infected skin was
in complete agreement with the FACS® analysis (unpub-
lished data). Hence, we can exclude that abrogation of DC
migration is due either to cell death of latex  cells or to
trapping of CD11c /latex  cells in the skin.
Bacteria Irreversibly Block DC Differentiation from Mono-
cytes. Next, we addressed the issue of whether DC differ-
entiation from monocytes was taking place normally in the
inflamed tissue. We derived monocytes from peritoneal la-
vage (21) of Ly5.2 mice as described in Materials and
Methods to yield latex  monocytes. The majority of col-
lected latex  cells displayed typical features of inflammatory
monocytes (Fig. 6 A: intermediate levels of Ly6-c, inter-
mediate F4/80 [not depicted], and I-Ab, no CD11c, no
B7.2, no CD40, and low CD115 [M-CSF receptor]). The
absence of CD11c  cells suggests that classical DCs are not
present. F4/80hi macrophages, likely derived from resident
macrophages, were present but represent  10% of mono-
cyte-derived cells (unpublished data) and were surprisingly
less efficient at engulfing microspheres than their newly re-
cruited counterparts. Thus, although a few of the recov-
ered cells could have originated from resident macro-
phages, most must derive from newly recruited monocytes.
FITC latex  monocytes were injected i.d. in C57/BL6J
Ly5.1 mice either alone or together with bacteria at a ratio
of 25 bacteria to 1 monocyte. Adoptively transferred
monocytes could be tracked in recipient mice as CD45.2 /
latex  cells. As shown in Fig. 6 B, latex  adoptively trans-
ferred cells could be detected in DLNs only when injected
in the absence of bacteria. LN latex  cells displayed a DC
phenotype (Fig. 5 B) similarly to endogenously migrated
monocytes (5). Many migrated monocytes gave rise to ma-
ture latex  DCs having high expression of MHC-II, B7.2,
and CD40 (Fig. 5 B). In situ these cells were found subja-
cent to the B cell follicles within the T cell zone and in the
interfollicular spaces, where they stained positively for
DEC-205 (Fig. 5 C).
As per our earlier conclusion, nonmigrated latex  skin
cells of mice coinjected with latex and bacteria did not dis-
play any marker of DCs (Fig. 6 A). Moreover, when latex 
cells were collected from the skin inflammatory reaction
and reinjected i.d. in the absence of bacteria, they did not
produce migrating DCs, indicating that the block of DC
differentiation from monocytes was irreversible (Fig. 6 C).
The only latex  cells that could be found in the LN were
of recipient origin. Consistently, culture of latex  cells
from infected skin in conditioned medium containing
GM-CSF for up to 4 d did not yield to DCs (Fig. 6 A). By
contrast, peritoneal monocytes rapidly up-regulated the
expression of CD11c, costimulatory molecules (CD40 and
B7.2), and MHC class II (I-Ab) after 2 d of culture in DC-
conditioned medium (Fig. 6 A). These results support the
hypothesis that i.d. bacterial injection irreversibly inhibits
DC differentiation from inflammatory monocytes recruited
at the site of infection, thus explaining their inability to
migrate to DLNs.
Figure 7. LPS is not fully responsible for bacteria-dependent inhibition
of DC differentiation and also exerts its effect on recruited inflammatory
cells. (A) C3H/HeN and C3H/HeJ mice were i.d. injected with latex 
inflammatory monocytes. Monocytes were derived from either HeN or
HeJ mice, and then i.d. injected alone or together with 107 CFUs of
bacteria or 10  g LPS in the syngeneic and congenic strain. Latex  cells
were recovered from DLNs 3 d after injection. Bacteria always impede
migration of latex  monocytes. The block of DC migration induced by
LPS is completely reverted when injecting nonresponsive monocytes
(HeJ monocytes) but not when injecting LPS-responsive monocytes
(HeN monocytes) into nonresponsive mice (HeJ mice). (B) The block of
DC differentiation from monocytes is mediated by a concerted action
between bacteria and inflammatory cells. Thioglycollate-elicited inflam-
matory monocytes were enriched after sorting of latex-bearing cells and
were incubated either alone or with Salmonella (50:1 bacteria/monocytes)
in GM-CSF–containing medium. Maximum 50% inhibition of DC
differentiation was observed after incubation of inflammatory cells with
bacteria. 100% inhibition was observed when increasing ratios of inflam-
matory cells were added in addition to bacteria.T
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Inhibition of DC Differentiation Is Not Due Only to TLR4
Engagement. We have shown that i.d. injection of
amounts of LPS  1  g induces a block of DC migration
similar to that induced by the bacteria. Thus, we have in-
vestigated whether the effect exerted by the bacteria was
primarily mediated by LPS. We have analyzed the migra-
tory capacity of adoptively transferred inflammatory mono-
cytes coinjected with LPS or bacteria in mice nonresponsive
to LPS (C3H/HeJ) or in mice responsive to LPS (C3H/
HeN). As expected, HeN monocytes were unable to mi-
grate in LPS-responsive mice (HeN) when coinjected both
with LPS or bacteria (Fig. 7 A). By contrast, HeJ monocytes
were perfectly capable of migrating in LPS-nonresponsive
mice only when LPS but not bacteria was coinjected (Fig. 7
A). As C3H/HeJ mice have a point mutation which affects
only the function of TLR4, we can conclude that when we
injected bacteria, other bacterial components that can trans-
duce via TLRs other than TLR4 are also involved in the
block of DC differentiation. We investigated whether the
inhibitory effect of bacteria might be reversed in MyD88 / 
mice. In this strain, migration of monocyte-derived DCs
was normal in the absence of bacteria, and the block in-
duced by bacteria was not reversed. If the effects of bacte-
ria are dependent on TLRs, the response must involve
MyD88-independent signaling pathways (22) that may
dominate over or be redundant with MyD88 signaling.
The Inhibitory Effect of Bacteria Is Mediated in Conjunction
with Inflammatory Cells. Interestingly, when HeN mono-
cytes were coinjected with LPS into the LPS nonrespon-
sive strain their migratory capacity was not reverted. There
could be two explanations, not mutually exclusive, that ei-
ther LPS itself blocks to some extent DC differentiation
from monocytes or that some contaminating inflammatory
cells might release factors that play a role in inhibiting
monocyte differentiation to DCs. The latter possibility is
supported by the fact that LPS nonresponsive monocytes
are unable to differentiate to DCs into LPS-responsive re-
cipients, suggesting that the inflammatory environment,
rather than a cell autonomous effect, induced by LPS plays
a decisive role in the development or function of migratory
DCs (Fig. 7 A). However, we could not exclude that bac-
teria or LPS might have a direct effect on DC differentia-
tion. Thus, we derived inflammatory monocytes from
peritoneal wash as described above, and we purified the
population of inflammatory monocytes by sorting latex 
cells. We then incubated the cells with or without external
bacteria in GM-CSF–containing medium and we analyzed
the percentage of cells giving rise to CD11c  cells. As
shown in Fig. 7 B, the presence of bacteria reduced 50% of
the potential of inflammatory monocytes to differentiate
into DCs. A much more robust inhibition of differentia-
tion, more closely resembling the massive block observed
in vivo, was observed when we added back even a rela-
tively small number of the latex  inflammatory cells from
the cell sort. From Fig. 6 (where unsorted peritoneal cells
were used), we know that leaving the latex  inflammatory
cells in the 2-d culture containing GM-CSF does not ad-
versely affect the differentiation of monocytes into DCs in
the absence of bacteria. When inflammatory cells (predom-
inantly neutrophils) are present with bacteria and labeled
monocytes, the differentiation of the monocyte-derived
cells to DCs nearly ablated. These data suggest that com-
plete inhibition of DC differentiation is achieved by a com-
bination of events mediated by the bacteria and by the in-
flammatory cells recruited at the infection site.
Single Action of IL-10, IL-6, IL-12, or IFN-  Is Not Suffi-
cient to Block DC Differentiation. To identify soluble fac-
tors released by inflammatory cells and responsible for the
block of DC differentiation, we evaluated the role of cyto-
kines recognized as having a negative effect on DC differ-
entiation. We found that during the first and second day af-
ter infection, high amounts of IL-10 (corresponding to 300
and 500 pg, respectively) were detected by ELISA in the
dissected tissue corresponding to the site of injection. IL-10
plays a regulatory role on DC function by blocking either
DC differentiation from monocytes (10, 11) or DC and
LCs maturation and function induced by several stimuli
(23–26). Moreover, IL-10 converts monocytes into macro-
phages with increased antibacterial activity (15) and reduces
the migratory capacity of DCs infected with Mycobacterium
bovis  bacillus calmette guerin (27). Thus, we investigated
whether IL-10 released during inflammation played a role
Figure 8. Absence of IL-12-p40, but not p35, IL-10, IL-6, or IFN- 
partly relieves the block imposed by LPS. (A) IL-10 neutralization with
anti–IL-10 antibodies does not restore DC mobilization from the periphery
to DLNs. Similar results were obtained in IL-10 KO mice. Latex  cells
recovered from the DLNs are shown 1, 2, or 3 d after injection in IL-10–
neutralized mice, and 3 d after injection in IL-10 KO mice. Results are
representative of three independent experiments. (B) Only IL-12-p40
KO mice can partly revert the block of latex  cell migration induced by
LPS injection. Migration of latex  cells was evaluated in different mice
strains lacking, respectively, the expression of IL-12-p35, IFN-  and IL-12-
p35, IL-12-p40, and IL-6. Latex microspheres were i.d. injected alone or
together with 10  g LPS.T
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in blocking DC differentiation and we coinjected neutral-
izing anti–IL-10 antibodies together with FITC latex only,
or with FITC latex and bacteria. As a control we injected
an isotype-matched irrelevant antibody. As shown in Fig. 8
A, IL-10 neutralization was not able to restore even par-
tially DC migration. Injection of latex beads in the pres-
ence of 107 CFUs of bacteria blocked DC migration also in
mice lacking IL-10 (Fig. 8 A), indicating that if IL-10 was
involved in modulating DC function, this was in combina-
tion with other factors. Another possible candidate respon-
sible for skewing monocyte differentiation to macrophages
is IL-6, which could be released by many inflammatory
cells (14). Thus, we investigated the role of IL-6 in the
block of DC differentiation and we injected FITC latex
beads in the absence or presence of bacteria (unpublished
data) or LPS in IL-6 KO mice. As shown in Fig. 8 B, the
absence of IL-6 does not restore the migration of latex 
beads, suggesting that IL-6 does not play a primary role in
the block of DC differentiation from monocytes. Finally, it
has been recently shown that IL-12 and IFN- , which are
important early in the primary response to Salmonella in-
fection (28), are released principally by neutrophils (29,
30). As the most populous cell type recruited early in the
inflammatory reaction are neutrophils, we asked whether
IL-12 or IFN-  could play a role in the block of DC mi-
gration either by influencing DC differentiation or the
generation of the inflammatory reaction. As shown in Fig.
8 B, in mice lacking either p35 or both IFN-  and p35, the
block of DC migration was not reverted.
IL-12-p40 Is Partly Involved in the Block of DC Migra-
tion. A prominent role for p40 in the clearance of Myco-
bacterium tuberculosis as well as of the bacterium Francisella
tularensis has been recently described (31, 32). Thus, we in-
vestigated the capacity of latex-bearing cells to migrate to
DLNs in p40 KO mice after coinjection of latex beads and
LPS. As shown in Fig. 8 B, DC migration was partially re-
stored in p40 KO mice, suggesting that p40 alone or its
combination with other proteins, such as p19 (33) rather
than p35, are important either in the block of DC differen-
tiation or migration and presumably in the containment of
bacteria at the site of infection.
Discussion
It is clear for various infections that the establishment of
containment reactions that limit expansion and spread of
infectious agents is protective for the host, a typical exam-
ple being the induction of granulomas (for review see ref-
erence 34). However, the requirement for microbial con-
tainment might have a parallel effect of inhibiting total cell
emigration from the inflamed area, including APCs, with
detrimental effects on the induction of adaptive immune
responses. We came across this possibility when we found
that recombinant Salmonellae injected i.d. are unable to in-
duce efficient adaptive immune responses to bacteria-asso-
ciated antigens (18). Here we have shown that indeed, i.d.
injection of S. typhimurium or LPS (at concentrations  1
 g) induce the initiation of local inflammatory reactions,
which impede the differentiation of DCs from monocytes
and their subsequent migration to DLNs.
The block of DC differentiation is due to a combination
of effects mediated both by the bacteria and by inflam-
matory cells recruited at the site of injection. In fact, in
vitro incubation of inflammatory monocytes with bacteria
blocked nearly 50% of their differentiation into DCs, con-
sistent with earlier analysis of the effects of LPS on the dif-
ferentiation of human monocytes to DCs in vitro (35).
More substantial inhibition, however, was observed when
monocytes were coincubated with bacteria and inflamma-
tory cells in vitro. This condition blocked completely DC
differentiation. A direct involvement in vivo of recipient
inflammatory cells after LPS injection was attested by the
migratory defect of adoptively transferred LPS-nonrespon-
sive inflammatory monocytes into LPS-responsive, but not
LPS-nonresponsive, mice. This highlights an unexpected
negative regulatory role of TLR4 engagement on DC dif-
ferentiation from precursor cells and poses a new perspec-
tive on TLRs. That is, TLR engagement may not un-
equivocally link innate and adaptive immune responses.
Although numerous studies show that inflammatory medi-
ators and engagement of TLRs can promote adaptive im-
mune responses by promoting maturation of DCs, the out-
come is quite different when monocytes, which are not a
priori committed to become DCs but can also become
macrophages, encounter the inflammatory/pathogenic sig-
nal before committing to the DC pathway of differentia-
tion in vivo.
The block of DC differentiation from monocytes corre-
lated with the inability of particulate or bacteria-associated
antigen to reach the DLN. We observed a progressive de-
cline of T cell activation toward particulate antigen (OVA
latex beads), which can gain access to DLNs primarily via
cellular transport (5) in the presence of increasing concen-
trations of coinjected Salmonellae. Accumulation of T cells
was also not found within the skin inflammatory infiltrate
(unpublished data), suggesting that our failure to find them
in DLN was not due to their preferential recruitment in the
inflammatory focus at the site of injection. We can also ex-
clude that bacteria might be toxic or affect the intrinsic mi-
gratory properties of fully differentiated DCs as reported for
Leishmania major (36, 37) because DCs preloaded in vitro
with bacteria and soluble OVA before injection in vivo
were not impaired in their capacity to stimulate T cells.
Consistent with the inability of Salmonella vaccination to
protect from tumor challenge, we observed very little T
cell proliferation to bacteria expressing OVA and only at a
high concentration of injected bacteria (107 CFUs), proba-
bly due to few bacteria freely migrating to the DLN. By
contrast, we did not detect any reduction in T cell prolifer-
ation after injection of soluble OVA with increasing con-
centrations of bacteria, indicating that soluble antigens can
freely enter afferent lymph to reach DLNs and be presented
by resident APCs.
Indeed, dissemination of free antigens might be the main
way in which adaptive responses develop against pathogens
that elicit strong local inflammatory responses.T
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As mentioned above, a prompt recruitment of inflamma-
tory cells was observed at the site of bacterial injection.
When latex alone is administered intracutaneously, the pre-
dominant cell types attracted to the site of injection are
mononuclear cells, including many monocytes. Very few
polymorphonuclear cells are observed (5). The inclusion of
bacteria in the injections may substantially modify the pro-
file of the recruited cells, as neutrophils are well known to
be recruited by bacterial products. Our analysis of the skin
inflammatory site supports this conclusion. We found by
microscopic analysis of the inflamed skin, the presence of
many macrophages and granulocytes. By contrast we could
hardly detect any cells having the typical phenotype of DCs.
It is likely that some, if not all, of the monocytes that are re-
cruited at the site of inflammation differentiate into highly
phagocytic cells as macrophages and are not available to de-
velop into migratory DCs. This is supported by the obser-
vation that DC differentiation is irreversibly inhibited by
bacteria because cells from infected skins were still unable to
differentiate into DCs after 4 d of culture in medium con-
taining GM-CSF, whereas inflammatory monocytes differ-
entiated into DCs already after 2 d of culture. We postu-
lated that cytokines released by the recruited inflammatory
cells might have a regulatory activity on DC differentiation.
However, we could not revert the block of DC migration
by the individual absence of several cytokines involved in
DC differentiation or in inflammation, i.e., IL-6, IL-10, IL-
12-p35, and IFN- , suggesting that the inhibition of DC
differentiation is probably due to the coexistence of multiple
events. The only cytokine KO mouse that partially reverted
the observed phenotype in the presence of LPS was IL-12-
p40 KO. p40 could act as a homodimer (p402) or together
with other proteins rather than p35 (i.e., p19 to yield IL-
23), and this is in agreement with data in the literature
showing a crucial role of p40, but not of p35, in bacterial
clearance (31, 32). Further, p402 has been reported to have
chemotactic (38) and activating properties on macrophages
and microglia (39). Thus, p40 could have similar properties
also on monocytes and somehow influence their differentia-
tion, migratory clearance, and function. The role of p40 in
DC differentiation from monocytes and whether its origin
from neutrophils explains the inhibitory effect of the inflam-
matory cells is under investigation.
In conclusion, these results tell us that when the skin is
accidentally injured, by a cut for instance, and the dermis is
exposed to environmental microorganisms, the immune
system responds with the induction of a vigorous innate re-
sponse aimed at microbial containment. We could envisage
the existence of a hierarchical mechanism, whereby an in-
flammatory focus delays the onset of the adaptive response
until the cellular (phagocyte) response has a chance to de-
velop in the periphery and clear the infecting agent. This is
achieved by (a) inhibiting monocyte differentiation into
DCs, which may favor the development of cells with
higher microbicidal potential, and (b) by blocking DC mo-
bilization to DLNs, which may reduce the possibility for
the pathogen to use DCs as carriers to reach DLNs. Thus,
we have identified a checkpoint in the induction of adap-
tive responses to bacteria that is the regulation of DC dif-
ferentiation from monocytes. Although this mechanism
would decrease the chances of microbial spreading, it could
be harnessed by intracellular bacteria particularly resistant to
phagocyte killing to hide from the immune system and cre-
ate a niche to their own interest.
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